Bath & Body Works Charts Turnaround Amid 2026 Squeeze

Bath & Body Works, Inc. ((BBWI)) has held its Q4 earnings call. Read on for the main highlights of the call.

Bath & Body Works, Inc. struck a cautiously optimistic tone on its latest earnings call, outlining a detailed multi‑year turnaround under its Consumer First Formula while acknowledging meaningful near‑term pressure. Management highlighted early wins in product innovation, cleaner inventory, and cost savings, but stressed that material financial benefits will skew toward 2026 and 2027 amid macro and margin headwinds.

Q4 Beat Masks Ongoing Top-Line Softness

Bath & Body Works reported Q4 net sales of $2.7 billion, down 2.3% year over year yet above the low end of guidance. Adjusted EPS of $2.05 declined roughly 2% but still exceeded expectations, signaling solid expense control and execution even as demand remains under pressure across key categories.

Innovation Momentum Underpins Turnaround Strategy

Management pointed to strong proof points from new products as evidence the Consumer First Formula is gaining traction. A new moisturizing hand soap is seeing very strong reviews and sell‑through, with productivity running at about double the gel format it replaced and a broader innovation pipeline planned for 2026 in body care, home fragrance, and soaps and sanitizers.

Franchises and Collaborations Drive Brand Heat

Flagship fragrance Champagne Toast delivered its best year ever, reinforcing the company’s ability to elevate and extend core franchises. The Disney Princess 2.0 collaboration performed in line with expectations, and leadership sees further opportunity in curated partnerships to refresh assortments and attract new or lapsed customers.

Amazon Entry Expands Marketplace Reach

The company launched on Amazon on February 20 with a curated 50‑SKU lineup and enhanced storytelling to reach shoppers beyond its own stores and site. Management has embedded roughly $50 million of incremental 2026 revenue, or about half a point of growth, from this expanded distribution, targeting both new and lapsed customers.

International Segment Delivers Robust Growth

International continues to be a bright spot, with Q4 net sales up 8.6% and system‑wide retail sales climbing 13%. Global partners opened 36 stores and closed seven in the quarter, finishing the year with 573 international locations after adding 44 net new stores, underscoring the brand’s global runway.

Disciplined Inventory and Evolving Store Fleet

Inventory ended the year down 5% versus 2025, leaving the business well positioned with clean stock heading into spring and supporting more responsive product flows. About 60% of stores are now off‑mall, and in North America the company opened 21 and closed 28 locations in Q4, producing 32 net new stores for the full year.

Solid Free Cash Flow and Returns, But Downshift Ahead

Bath & Body Works generated $865 million of free cash flow in fiscal 2025, including about $125 million of working‑capital benefit, and returned capital via $167 million in dividends and $400 million of share repurchases. Management expects free cash flow to step down to roughly $600 million in 2026, even after a $65 million settlement, as it leans into investments.

Fuel for Growth: $250 Million Cost-Savings Plan

To fund its strategic pivot, the company launched the Fuel for Growth program targeting $250 million of savings over two years. Approximately $175 million of those savings are included in 2026 guidance and are earmarked to support product innovation, marketing, and other Consumer First initiatives rather than fall straight to the bottom line.

Persistent Top-Line Pressure in 2026 Outlook

Despite operational actions, management expects net sales to decline again in fiscal 2026, guiding to a range of down 4.5% to down 2.5%. First‑quarter trends are even softer, with sales projected to fall 6% to 4%, reflecting continued category headwinds and a cautious consumer backdrop as the turnaround ramps.

Body Care and Seasonal Offerings Lag

Body care sales fell mid‑single digits in Q4, hurt by weaker performance in seasonal collections, particularly Holiday Traditions. Consumers signaled that body care assortments had become too predictable, reinforcing the need for fresher innovation and more excitement around key seasons to re‑ignite traffic and ticket growth.

Margins Set to Compress on Investments

The Q4 adjusted gross profit rate declined 100 basis points year on year to 45.7%, and the company expects further pressure. For 2026, management is guiding to a gross profit rate near 42.4%, reflecting lower merchandise margins tied to stepped‑up product investment and buying and occupancy deleverage on a smaller sales base.

Operating Expenses Rise on Investment and Deleverage

Q4 adjusted SG&A rate rose 90 basis points to 23.2%, and the outlook calls for a full‑year 2026 SG&A rate around 29.2%, with Q1 at roughly 32.3%. The company is deliberately spending into its strategy while also contending with sales deleverage, which together keep near‑term earnings under pressure despite cost‑saving efforts.

Tariffs and Costs Add Near-Term Earnings Noise

Tariff costs are another headwind, with Q1 2026 gross margin expected to absorb roughly 150 basis points of tariff impact compared with the prior year. While management views tariffs and product cost inflation as roughly neutral to earnings for 2026 overall, the quarterly cadence will be choppy and skewed toward earlier pressure.

Promotions Weigh on Pricing Power

Mix‑adjusted average unit retail slipped low single digits in Q4, underscoring ongoing price pressure. Management expects promotional intensity to remain comparable to 2025 and acknowledges that the brand’s long‑standing dependence on deals and discounts is a structural challenge it must gradually unwind as innovation improves perceived value.

Capital Allocation Shifts Away From Buybacks

The company does not assume any share repurchases in its 2026 plan as it rebalances capital priorities. Instead, it will redeem $284 million of notes due January 2027 in the first quarter and channel more cash toward funding the Consumer First strategy while maintaining leverage guardrails and its existing dividend.

EPS Contraction and Lower Free Cash Flow

Fiscal 2025 adjusted EPS came in at $3.21, down about 2%, and management expects a further step down in 2026 to a range of $2.40 to $2.65. Combined with the forecast decline in free cash flow to around $600 million, the guidance reinforces that investors face a transitional year before potential re‑acceleration.

Guidance Signals Transitional Year Before Payoff

For 2026 the company is planning for lower sales, a gross margin near 42.4%, an SG&A rate around 29.2%, and adjusted EPS between $2.40 and $2.65 with no buybacks assumed. Management expects about $175 million of Fuel for Growth savings, around $270 million of capital spending, mid‑ to high‑single‑digit international growth, modest square footage expansion, and roughly $50 million of benefit from Amazon and other distribution gains.

Bath & Body Works’ latest call paints a picture of a retailer in active reinvention, trading near‑term earnings and margin compression for a more durable growth algorithm built on innovation, expanded reach, and structural cost savings. For investors, the story hinges on patience: the operational groundwork is being laid now, but the true financial payoff may not fully emerge until 2027 and beyond.